Company: BLNE
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001641172-25-004793
Chunk: 222

Company: Beeline Holdings, Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1A
Chunk 222
---
 require it or expose us to substantial restrictive covenants or limitations, the consequences could be a material adverse
effect on our business, operating results, financial condition and prospects.

Further, certain of our outstanding
derivatives securities, including convertible preferred stock and warrants, contain anti-dilution price protection provisions which provide
for adjustments to conversion and exercise prices, and an increase in the shares underlying such securities, if we sell shares at a per
share price below the applicable conversion or exercise price. Therefore, to the extent we issue shares at prices that are lower than
these conversion and exercise prices and we do not obtain waivers of these provisions, these conversion and exercise prices will be lowered
to the new lower sale price, and the shares of common stock underlying such securities will increase accordingly. This would cause additional
dilution to our common stockholders and result in our receiving less cash upon exercise of warrants.

By virtue of the terms of the ELOC
Agreement or any At-The-Market Offering Agreement if and when we enter into such an agreement, it is not possible to predict the number
of shares we will sell nor the prices at which we will sell the shares in such transactions, the amount of proceeds we will raise and
the timing thereof including whether they will be sufficient for our working capital needs and business plans (including the timely payment
of our debt obligations), nor the consequences (including dilution to existing shareholders) which may result therefrom.

An active trading market for
our common stock may not develop.

With limited exceptions, the volume
of sales of our common stock has not been high. Although our common stock trades on Nasdaq, an active trading market for our shares may
never develop or be sustained. If an active market for our common stock does not develop, it may be difficult to sell our common stock
without depressing the market price for the common stock, or at all.

We are incurring significant
additional costs as a result of being a public company, and our management will be required to devote substantial time to compliance with
our public company responsibilities and corporate governance practices.

As a public company, we are incurring
increased costs associated with corporate governance requirements, including rules and regulations of the SEC under the Sarbanes-Oxley
Act, the Dodd-Frank Wall Street Reform and Customer Protection Act of 2010, and the Securities Exchange Act of 1934 (the “Exchange
Act”), as well as Nasdaq rules. These rules and regulations are expected to significantly increase